The highly anticipated documentary The Pink Pill: Sex, Drugs & Who Has Control officially arrived on Paramount+ on March 6, 2026. Directed by Aisling Chin-Yee, the film offers a deep dive into the decade-long crusade of entrepreneur Cindy Eckert. It highlights her high-stakes mission to bring Addyi, the first FDA-approved treatment for Hypoactive Sexual Desire Disorder in women, to the consumer market.

The film doesn't just focus on pharmaceutical science; it pulls back the curtain on systemic gender bias within the U.S. Food and Drug Administration (FDA). Eckert, who founded Sprout Pharmaceuticals, shares first-hand accounts of the hurdles she faced compared to the rapid approval of male-centric treatments like Viagra. The documentary has already gained significant traction on the festival circuit, securing the prestigious Audience Award at DOC NYC.

Produced by Everywoman Studios, the documentary features expert interviews and archival footage detailing the political and social pushback against women's sexual health products. Critics have praised Chin-Yee’s direction for transforming a complex corporate legal battle into a compelling narrative about bodily autonomy. Viewers can now stream the feature exclusively on Paramount+ following its successful limited theatrical run.